EVOとEVO+のインプラント可能なコラーマーレンズの実用的な安全性プロファイル:FDAの監視データに基づく遡及的研究
Qing Chen1, Shouxiang Ni2, Haijing Yan1
1National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
Ophthalmology and therapy
|August 23, 2025
まとめ
EVOとEVO+の植入可能なコラーマーレンズ (ICL) に関する有害事象 (AEs) が実用データから明らかになった. 視界のぼんやりと眼内圧の上昇は一般的であり,まれに重大な合併症が認められた.
科学分野:
- 眼科について
- 医療機器の監視
- 網膜 手術
背景:
- 植入用コラマーレンズ (ICL) の市場公開後の監視は,現実の有害事象 (AE) プロフィールを理解するために極めて重要です.
- EVOとEVO+ICLモデルは,継続的な安全監視を必要とする高度な眼内レンズ技術を表しています.
- FDAのMAUDEデータベースを利用することで,実際のAEデータの包括的な情報源が提供されます.
研究 の 目的:
- EVOおよびEVO+植入コラーマーレンズ (ICL) に関連する有害事象の特徴と評価.
- 合併症のパターンを特定するために,市場公開後の実際の監視データを分析する.
- 特定期間のICLにおける報告された有害事象の動向を評価する.
主な方法:
- EVOとEVO+のICL (球形とトリック) の17,482件のAE報告を2015年から2023年まで遡って分析した.
- 複製された/不完全な記録を除外し,次に4つのレンズモデル/タイプのグループに分類する.
- 合併症の分類とAE傾向の記述的統計的分析のための上級眼科医による独立したレビュー.
主要な成果:
- AEの報告の半分以上は臨床的兆候を示さなかった. EVO+モデルでは,視力不透明が最も頻繁な苦情であった.
- 眼内圧の上昇と緑内障は,EVO+受容者においてより一般的であった.
- 報告されたAEsの一貫した上昇傾向が観察されました.
結論:
- 現実世界のデータ分析は,ICLインプラントの主要な合併症分布の洞察を提供します.
- 珍しい有害事象の全面的な報告は,外科医の準備と患者のカウンセリングを向上させることができます.
- AEのプロフィールを理解することで ICLでの手術の改善と患者の成果が得られます.
さらに関連する動画
関連する概念動画
Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
Glaucoma: Overview
749
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
749
Angle Closure Glaucoma: Treatment
674
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
674
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K


